MLX 365 meets our commitment to undertake a further consultation on specific proposals designed to strengthen the medicines supply chain in the UK. It follows and builds on responses to ideas set out in an earlier consultation (MLX 357) undertaken from 18 December 2008 – 13 March 2009. The overall aim of these proposals is to provide a significant strengthening of controls over the movement of medicines throughout the legitimate supply chain and provide greater protection against the risk of counterfeit medicines reaching patients in the UK.
Please note that the deadline for responses to this consultation has now been extended until 29 March 2010.
Responses should be sent to:
Ms Elizabeth Evans
Medicines and Healthcare products Regulatory Agency
1 Nine Elms Lane
Tel: 020 7084 2046
Fax: 020 7084 2387
- Public consultation (MLX 365): Consultation on measures to strengthen the medicines’ supply chain and reduce the risk from counterfeit medicines (127Kb)
- Pharmacy wholesaling – The legal background (MLX 365) (134Kb)
- Impact Assessment of measures to strengthen the medicines' supply chain and reduce the risk from counterfeit medicines (MLX 365) (6714Kb)
- Consultation on measures to strengthen the medicines' supply chain and reduce the risk from counterfeit medicines - consultation list (MLX 365) (764Kb)